Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable heart muscle disease that causes sudden cardiac death in the young. Inflammatory myocardial infiltrates have been described at autopsy and on biopsy, but there are few data on the presence of myocarditis in living patients with ARVC using non-invasive imaging techniques. FDG-PET is a validated technique for detecting myocardial inflammation in clinically suspected myocarditis. We aimed to determine the prevalence of myocardial inflammation in patients with ARVC using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). METHODS AND RESULTS We performed a retrospective analysis of a single centre cohort of patients with ARVC referred for FDG-PET scans between 2012 and 2017 for investigation of symptoms or suspected device infection. Sixteen patients (12 male; age 42 ± 13 years) with a definite diagnosis of ARVC were identified. Seven had positive FDG-PET scans, two of whom had cardiac sarcoidosis on endomyocardial biopsy. Of the remaining five, two carried pathogenic desmoplakin mutations. FDG uptake was found in the left ventricular myocardium in all cases. One patient also had right ventricular uptake. CONCLUSION In this exploratory study, we show that some patients with ARVC have evidence for myocardial inflammation on FDG-PET, suggesting that myocarditis plays a role in disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, Dystrophy, or Myocarditis?
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.983 · Cited by 890
Smith, E. D., Lakdawala, N. K., Papoutsidakis, N., Aubert, G., Mazzanti, A., McCanta, A. C., Agarwal, P. P., Arscott, P., Dellefave-Castillo, L. M., Vorovich, E. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044934 · Cited by 504
Pilichou, K., Remme, C. A., Basso, C., Campian, M. E., Rizzo, S., Barnett, P., Scicluna, B. P., Bauce, B., van den Hoff, M. J. B., de Bakker, J. M. T., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090641 · Cited by 210
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
Chelko, S. P., Asimaki, A., Andersen, P., Bedja, D., Amat-Alarcon, N., DeMazumder, D., Jasti, R., MacRae, C. A., Leber, R., Kleber, A. G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85923 · Cited by 180
Genetics of Myocarditis in Arrhythmogenic Right Ventricular Dysplasia
Lopez-Ayala, J. M., Pastor-Quirante, F., Gonzalez-Carrillo, J., Lopez-Cuenca, D., Sanchez-Munoz, J. J., Oliva-Sandoval, M. J., & Gimeno, J. R. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.001 · Cited by 140
Campuzano, O., Alcalde, M., Iglesias, A., Barahona-Dussault, C., Sarquella-Brugada, G., Benito, B., Arzamendi, D., Flores, J., Leung, T. K., Talajic, M., et al. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201022 · Cited by 90
Research works printed but not linked: 28
- Basso, 2009, Arrhythmogenic right ventricular cardiomyopathy, Lancet, 373, 1289, 10.1016/S0140-6736(09)60256-7 · DOI · Paper page
- Burke, 1998, Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases?, Circulation, 97, 1571, 10.1161/01.CIR.97.16.1571 · DOI · Paper page
- Fontaine, 1990, Congenital and acquired right ventricular dysplasia, Arch. Mal. Coeur Vaiss., 83, 915
- Fornes, 1998, Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia–an autopsy study of 20 forensic cases, J. Forensic Sci., 43, 777, 10.1520/JFS14306J · DOI
- Lobo, 1992, Right ventricular dysplasia: morphological findings in 13 cases, Can. J. Cardiol., 8, 261
- Valente, 1998, In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy, Am. J. Pathol., 152, 479
- Wicks, 2018, Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis, Eur. Heart J. Cardiovasc. Imaging, 19, 757, 10.1093/ehjci/jex340 · DOI · Paper page
- Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria, Eur. Heart J., 31, 806, 10.1093/eurheartj/ehq025 · DOI · Paper page
- Tahara, 2010, Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis, JACC Cardiovasc. Imaging, 3, 1219, 10.1016/j.jcmg.2010.09.015 · doi:10.1016/j.jcmg.2010.09.015
- Basso, 2008, Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria, Eur. Heart J., 29, 2760, 10.1093/eurheartj/ehn415 · DOI · Paper page
- Borgquist, 2014, The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria, Eur. Heart J. Cardiovasc. Imaging, 15, 1219, 10.1093/ehjci/jeu109 · DOI
- Sen-Chowdhry, 2008, The utility of magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular cardiomyopathy, Curr. Opin. Cardiol., 23, 38, 10.1097/HCO.0b013e3282f2c96e · DOI
- Bohnen, 2017, Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis, Eur. Heart J. Cardiovasc. Imaging, 18, 744, 10.1093/ehjci/jex007 · DOI
- Becker, 2001, The role of nuclear medicine in infection and inflammation, Lancet Infect. Dis., 1, 326, 10.1016/S1473-3099(01)00146-3 · DOI
- Campian, 2010, Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Eur. J. Nucl. Med. Mol. Imaging, 37, 2079, 10.1007/s00259-010-1525-y · DOI · Paper page
- Lawal, 2016, F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection, Br. Med. Bull., 120, 55, 10.1093/bmb/ldw035 · DOI
- Hofmann, 1993, Chronic (or healed) myocarditis mimicking arrhythmogenic right ventricular dysplasia, Eur. Heart J., 14, 717, 10.1093/eurheartj/14.5.717 · DOI
- Patrianakos, 2012, Arrhythmogenic right ventricular cardiomyopathy/dysplasia and troponin release. Myocarditis or the “hot phase” of the disease?, Int. J. Cardiol., 157, e26, 10.1016/j.ijcard.2011.09.017 · DOI
- Sabel, 1990, Arrhythmogenic right ventricular dysplasia in brother and sister: is it related to myocarditis?, Pediatr. Cardiol., 11, 113, 10.1007/BF02239576 · DOI
- Mavrogeni, 2013, Naxos disease evolution mimicking acute myocarditis: the role of cardiovascular magnetic resonance imaging, Int. J. Cardiol., 166, e14, 10.1016/j.ijcard.2012.12.078 · DOI
- Bauce, 2005, Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations, Eur. Heart J., 26, 1666, 10.1093/eurheartj/ehi341 · DOI · Paper page
- Fang, 2012, Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease, Pulm. Circ., 2, 365, 10.4103/2045-8932.101651 · DOI
- Hauck, 1989, Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error, Mayo Clin. Proc., 64, 1235, 10.1016/S0025-6196(12)61286-5 · DOI · Paper page
- Djouadi, 2009, A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy, Cardiovasc. Res., 84, 83, 10.1093/cvr/cvp183 · DOI · Paper page
- Kim, 2013, Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs, Nature, 494, 105, 10.1038/nature11799 · DOI · Paper page
- Ohira, 2008, Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis, Eur. J. Nucl. Med. Mol. Imaging, 35, 933, 10.1007/s00259-007-0650-8 · DOI · Paper page
- Schneider, 2014, Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment, Eur. Heart J., 35, 312, 10.1093/eurheartj/eht335 · doi:10.1093/eurheartj/eht335
- Philips, 2014, Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear, Circ. Arrhythmia Electrophysiol., 7, 230, 10.1161/CIRCEP.113.000932 · DOI · Paper page
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citationMyocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Smith, E. D., Lakdawala, N. K., Papoutsidakis, N., Aubert, G., Mazzanti, A., McCanta, A. C., Agarwal, P. P., Arscott, P., Dellefave-Castillo, L. M., Vorovich, E. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044934 · Cited by 504
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench
Peretto, G., Sommariva, E., Di Resta, C., Rabino, M., Villatore, A., Lazzeroni, D., Sala, S., Pompilio, G., & Cooper, L. T. (2023) · Biomolecules · doi:10.3390/biom13040646 · Cited by 37
Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
“…is a major criterion for diagnosis of sarcoidosis in the 2016 Japanese Cardiovascular Society on diagnosis and treatment of Cardiac Sarcoidosis [119], whereas the 2014 Heart Rhythm Society expert consensus considers as a histological criterion only the recognition of non-caseous granulomas [120].”
BackgroundResult
Metadata
- Authors
- Protonotarios, A., Wicks, E., Ashworth, M., Stephenson, E., Guttmann, O., Savvatis, K., Sekhri, N., Mohiddin, S. A., Syrris, P., Menezes, L., & Elliott, P.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 284
- Pages
- 99-104
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2898551602
- Cited by
- 85
- References
- 6
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- European Society of Cardiology (R-2017-071)
- University College London
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy. https://app.cochat.ai/papers/10.1016/j.ijcard.2018.10.083
- The paper
- Protonotarios, A., Wicks, E., Ashworth, M., Stephenson, E., Guttmann, O., Savvatis, K., Sekhri, N., Mohiddin, S. A., Syrris, P., Menezes, L., & Elliott, P. (2019). Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2018.10.083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.